http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2550398-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7962109cd4763907b82b66760cd0ae8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-824 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-08 |
filingDate | 2006-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f48fa01b8b097c87cfb64643ae74c9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_646e968332b7cb98f972d4df9a8548d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87ea7d5ef113075281d076d95b73b817 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec55a6b66725068137cd2aaa28c6786f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6c965373d34e0709f78601833e42c4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adb9d1766d5704ea96e73fb98a0f6306 |
publicationDate | 2015-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2550398-T3 |
titleOfInvention | Cross-linked cyclic amine compounds and agents for pest control |
abstract | Cyclic amine compounds represented by formula (1): ** Formula ** or salts thereof or N-oxides thereof, in which Cy1 represents one selected from the group consisting of phenyl, naphthalene-1- ilo, fury-2-yl, fury-3-yl, thiophene-2-yl, thiophene-3-yl, pyrrole-2-yl, pyrrole-3-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5- yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, isothiazol-3-yl, isothiazole- 4-yl, isothiazol-5-yl, imidazol-2-yl, imidazol-4- yl, imidazol-5-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazole-5-yl, 1,3, 4-oxadiazol-2-yl, 1,3,4-thiadiazol-2-yl, 1,2,3-triazol-4-yl, 1,2,4-triazol-3-yl, 1,2,4- triazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrazin-2-yl, pyrimidin-2-yl, pyrimidin- 4-yl, pyrimidin-5-yl, 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl, X represents one selected from the group consisting of oxygen, sulfur, nitrogen sulfini lo and sulfonyl; R1 a and R2 a, R1 a and R4 a, R2 a and R3 a or R3 a and R4 a together form saturated rings; R1 a, R1 b, R2 a, R2 b, R3 a, R3 b, R4 a, R4 and R5, which do not form the saturated rings, are each independently hydrogen, hydroxyl, halogen, amino, nitro, cyano, formyl, alkyl, alkoxycarbonyl, alkoxy, haloalkyl, haloalkoxy, alkylthiocarbonyl, alkylsulfonylamino, haloalkylsulfonylamino, bis (alkylsulfonyl) amino, bis (haloalkylsulfonyl) amino or aryl; Cy2 represents one selected from the group consisting of aromatic hydrocarbon, fury-2-yl, fury-3-yl, thiophene-2-yl, thiophene-3-yl, pyrrole-2-yl, pyrrole-3-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5- yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol- 5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, imidazol-4-yl, imidazol-5- yl, pyrazol-3-yl, pyrazole-4-yl, pyrazole-5- yl, 1,3,4-oxadiazol-2-yl, 1,3,4-thiadiazol-2-yl, 1,2,3-triazol-4-yl, 1,2,4-triazol-3- yl, 1,2,4-triazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrazin-2-yl, pyrimidine- 2-yl, pyrimidin-4-yl, pyrimidin-5-yl, 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl; Cy1, Cy2 and the nitrogen of X may be optionally substituted with at least one substituent selected from the group consisting of hydroxyl, thiol, halogen, cyano, nitro, formyl, amino, methylamino, benzylamino, anilino, dimethylamino, diethylamino, Phenylethylamino, alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy, aryloxy, heteroaryloxy, haloalkyl, haloalkoxy, alkylthiocarbonyl, alkylsulfonylamino, arylsulfonylamino, heteroarylsulfonylamino, alkylcarbonylamino, alkoxycarbonylamino, haloalkylsulphonylalkyl-alkylamino-amino-alkylamino-amino-alkylsulfonyl-alkylamino-amino-alkylsulfonyl-alkylamino-amino-alkylsulfonyl-alkylamino-amino-alkylsulfonyl-amino-alkylsulfonyl-alkylsulfonyl-amino-alkylsulfonyl-alkylsulfonyl-alkylsulfonyl-alkylarylsulfonyl-alkylsulfonyl-alkylarylsulphonylamino-amino-alkylsulfonyl-alkylaryls. N'-phenylhydrazino, N'-methoxycarbonylhydrazino, N'-acetylhydrazino, N'-methylhydrazino, alkoxycarbonyl, aryl, aralkyl, unsaturated 5-membered heterocycle, unsaturated 5-alkyl heterocycle, unsaturated 6-membered heterocycle, 6-membered heterocycle unsaturated-alkyl, saturated heterocyclic group, saturated heterocyclic alkyl, N-dimethylaminoiminomethyl, 1- N-feniliminoetilo, Nhidroxiiminometilo, N-methoxyiminomethyl, N'-metilhidrazinocarbonilo, N'-fenilhidrazinocarbonilo, hydrazinocarbonyl, aminocarbonyl, dimethylaminocarbonyl, N-phenyl-N-methylaminocarbonyl, alkylthio, alkenylthio, alkynylthio, arylthio, heteroarylthio, aralkylthio, alkylsulfonyl, alkenylsulfonyl, alkynylsulfonyl, arylsulfonyl, heteroarylsulfonyl, aralkylsulfonyl and groups represented by formulas (a) to (c) below: ** Formula ** in formulas (a), (b) and (c), R6 and R7 represent, each independently, hydrogen, alkyl, alkenyl, alkynyl, aromatic hydrocarbon, unsaturated 5-membered heterocycle, unsaturated member heterocycle-alkyl, unsaturated 6-member heterocycle, unsaturated 6-member heterocycle-alkyl, saturated heterocycle, saturated heterocyclic alkyl, amino, a hydrocarbonoxy or hydrocarbonium, R8 and R11 each independently represent hydrogen, alkyl, alkenyl, alkynyl, aromatic hydrocarbon or, unsaturated 5-membered heterocycle, unsaturated 5-membered heterocycle-alkyl, unsaturated 6-membered heterocycle 5, unsaturated 6-membered heterocycle-alkyl, saturated heterocycle, saturated heterocyclic alkyl, or amino; R9 represents hydrogen, alkyl, alkenyl, alkynyl or aromatic hydrocarbon; R10 represents hydrogen, alkyl, alkenyl, alkynyl, aromatic hydrocarbon, unsaturated 5-membered heterocycle, unsaturated 5-membered heterocycle-alkyl, unsaturated 6-membered heterocycle, unsaturated 6-membered heterocycle-alkyl, saturated heterocycle, or saturated heterocyclic alkyl; Y and Z each independently represent oxygen or nitrogen; R6 and R7, R8 and R9, and R10 and R11 can be joined to form rings and both groups in the pair represent functional groups, which can be integrated to form a ring, with the proviso that Cy2 is furán-2-ilo, furán- 3-yl, thiophene-2-yl, thiophene-3-yl, pyrrole-2-yl, pyrrole-3-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, thiazol-2- ilo, thiazol-4-yl, thiazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, imidazol-4-yl, imidazol-5-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, 1,3,4-oxadiazol-2- yl, 1,3,4-thiadiazole- 2-yl, 1,2,3-triazol-4-yl, 1,2,4-triazol-3-yl, 1,2,4-triazol-5-yl, pyridin-2-yl, pyridine-3- ilo, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrazin-2-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, 1,3,5- triazin-2-yl and 1,2,4-triazin-3-yl unsubstituted or substituted, when R1 and R2 form a jointly saturated ring and Cy1 is an unsubstituted or substituted phenyl, and Cy2 is a substituted pyridin-2-yl having one or more cyanos as a substituent when Cy1 is an unsubstituted or substituted phenyl and Cy2 is a pyridin-2-yl. |
priorityDate | 2005-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 634.